Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1955 1
1995 1
1996 1
1997 2
1998 1
1999 4
2000 5
2001 6
2002 3
2003 5
2004 6
2005 4
2006 8
2007 14
2008 13
2009 10
2010 5
2011 6
2012 3
2013 5
2014 4
2015 1
2016 2
2017 2
2018 6
2019 4
2020 1
2021 5
2022 6
2023 3
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Results by year

Filters applied: . Clear all
Page 1
S3-Leitlinie Magenkarzinom – Diagnostik und Therapie der Adenokarzinome des Magens und des ösophagogastralen Übergangs – Langversion 2.0 – August 2019. AWMF-Registernummer: 032/009OL.
Moehler M, Al-Batran SE, Andus T, Arends J, Arnold D, Baretton G, Bornschein J, Budach W, Daum S, Dietrich C, Ebert M, Fischbach W, Flentje M, Gockel I, Grenacher L, Haier J, Höcht S, Jakobs R, Jenssen C, Kade B, Kanzler S, Langhorst J, Link H, Lordick F, Lorenz D, Lorenzen S, Lutz M, Messmann H, Meyer HJ, Mönig S, Ott K, Quante M, Röcken C, Schlattmann P, Schmiegel WH, Schreyer A, Tannapfel A, Thuss-Patience P, Weimann A, Unverzagt S. Moehler M, et al. Among authors: kanzler s. Z Gastroenterol. 2019 Dec;57(12):1517-1632. doi: 10.1055/a-1018-2516. Epub 2019 Dec 11. Z Gastroenterol. 2019. PMID: 31826284 German. No abstract available.
Update on autoimmune hepatitis.
Teufel A, Galle PR, Kanzler S. Teufel A, et al. Among authors: kanzler s. World J Gastroenterol. 2009 Mar 7;15(9):1035-41. doi: 10.3748/wjg.15.1035. World J Gastroenterol. 2009. PMID: 19266594 Free PMC article. Review.
Apoptosis and the liver.
Kanzler S, Galle PR. Kanzler S, et al. Semin Cancer Biol. 2000 Jun;10(3):173-84. doi: 10.1006/scbi.2000.0318. Semin Cancer Biol. 2000. PMID: 10936067 Review.
Genetics of hepatocellular carcinoma.
Teufel A, Staib F, Kanzler S, Weinmann A, Schulze-Bergkamen H, Galle PR. Teufel A, et al. Among authors: kanzler s. World J Gastroenterol. 2007 Apr 28;13(16):2271-82. doi: 10.3748/wjg.v13.i16.2271. World J Gastroenterol. 2007. PMID: 17511024 Free PMC article. Review.
Foamy virus integration.
Juretzek T, Holm T, Gärtner K, Kanzler S, Lindemann D, Herchenröder O, Picard-Maureau M, Rammling M, Heinkelein M, Rethwilm A. Juretzek T, et al. Among authors: kanzler s. J Virol. 2004 Mar;78(5):2472-7. doi: 10.1128/jvi.78.5.2472-2477.2004. J Virol. 2004. PMID: 14963145 Free PMC article.
Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure.
Dietz J, Müllhaupt B, Buggisch P, Graf C, Peiffer KH, Matschenz K, Schattenberg JM, Antoni C, Mauss S, Niederau C, Discher T, Trauth J, Dultz G, Schulze Zur Wiesch J, Piecha F, Klinker H, Müller T, Berg T, Neumann-Haefelin C, Berg CP, Zeuzem S, Sarrazin C; German HCV Resistance Study Group; University Hospitals; Academic Hospitals; Local study sites (private practices), Germany. Dietz J, et al. J Hepatol. 2023 Jan;78(1):57-66. doi: 10.1016/j.jhep.2022.08.016. Epub 2022 Aug 27. J Hepatol. 2023. PMID: 36031158
[Autoimmune liver disease: diagnosis and therapy].
Bayer EM, Schramm C, Kanzler S, Lohse AW. Bayer EM, et al. Among authors: kanzler s. Z Gastroenterol. 2004 Jan;42(1):19-30. doi: 10.1055/s-2004-812686. Z Gastroenterol. 2004. PMID: 14997400 Review. German.
Adjuvant Treatment with S-1 in Patients after R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction: A Multicenter Phase I/II Feasibility Study (GMBH-STO-0114).
Heinrich K, Heinemann V, Stintzing S, Müller L, Ettrich TJ, Büchner-Steudel P, Geißler M, Trojan J, Moosmann N, Folprecht G, Schmidt J, Kanzler S, Kullmann F, Moulin JC, Werner J, Angele MK, Probst V, Held S, Schulz C, Boukovala M. Heinrich K, et al. Among authors: kanzler s. Oncol Res Treat. 2024;47(6):251-261. doi: 10.1159/000538143. Epub 2024 Apr 2. Oncol Res Treat. 2024. PMID: 38565089 Free PMC article. Clinical Trial.
Efficacy and quality of life for FOLFOX/bevacizumab +/- irinotecan in first-line metastatic colorectal cancer-final results of the AIO CHARTA trial.
Schmoll HJ, Mann J, Meinert F, Garlipp B, Borchert K, Vogel A, Goekkurt E, Kaiser U, Hoeffkes HG, Rüssel J, Kanzler S, Edelmann T, Forstbauer H, Göhler T, Hannig C, Hildebrandt B, Roll C, Bokemeyer C, Steighardt J, Cygon F, Ibach S, Stein A, Tintelnot J. Schmoll HJ, et al. Among authors: kanzler s. Br J Cancer. 2024 Feb;130(2):233-241. doi: 10.1038/s41416-023-02496-4. Epub 2023 Nov 23. Br J Cancer. 2024. PMID: 37996507 Free PMC article.
Nanoliposomal irinotecan and fluorouracil plus leucovorin versus fluorouracil plus leucovorin in patients with cholangiocarcinoma and gallbladder carcinoma previously treated with gemcitabine-based therapies (AIO NALIRICC): a multicentre, open-label, randomised, phase 2 trial.
Vogel A, Saborowski A, Wenzel P, Wege H, Folprecht G, Kretzschmar A, Schütt P, Jacobasch L, Ziegenhagen N, Boeck S, Zhang D, Kanzler S, Belle S, Mohm J, Gökkurt E, Lerchenmüller C, Graeven U, Pink D, Götze T, Kirstein MM. Vogel A, et al. Among authors: kanzler s. Lancet Gastroenterol Hepatol. 2024 Aug;9(8):734-744. doi: 10.1016/S2468-1253(24)00119-5. Epub 2024 Jun 10. Lancet Gastroenterol Hepatol. 2024. PMID: 38870977 Free article. Clinical Trial.
130 results